News & Events

Read QuantuMDx’s latest news to stay up to date with the company, its products, solutions and services.

News

QuantuMDx team at North East Medical Life Science Awards

QuantuMDx Wins Made in North East Medical Life Sciences Award 2022

NEWCASTLE UPON TYNE, UK, 25 MARCH 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce that it has won the Medical Life Sciences award at the Made in North East Awards 2022. The Made in North East Awards applaud quality…

News

A box full of small medical jars with white lids

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

NEWCASTLE UPON TYNE, UK, 10 MARCH 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its…

News

Martin Walton appointed as Chief Financial Officer

NEWCASTLE UPON TYNE, UK, 24 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), is pleased to announce…

News

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

NEWCASTLE UPON TYNE, UK, 22 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its rapid PCR SARS-CoV-2 test, with the multiplex Q-POC™ platform, has been approved for continued sales in the UK under the UK Health Security Agency’s Medical…

Previous Next

CAPTURE-XT explained

Sample cleanup and pathogen concentration

Future development

A novel microfluidic lab-on-a-chip sample clean up and cell concentration technology. Available as a prototype.

Close up of tubercolosis under microscope

Tuberculosis - the challenge

RISK6 explained

Simplified Workflow

Future development

A multiplex PCR laboratory assay to detect host-response-mediated mRNA transcripts present in whole blood. For Research Use Only.

A supercharged platform, with a fast workflow

A smooth user experience with an intuitive interface

A ready to use solution, with all its simplicity, accuracy and speed

A ton of tech behind every result, with intelligent multilingual software algorithms.

A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system

A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Care.

High quality multiplex PCR testing, as simple as a lateral flow test

A sustainable respiratory infection control solution with the quality of lab-based PCR testing

Results you can trust, with a simple procedure and reliable testing

Meet the challenges of the Winter Season with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Care.

News & Events

QuantuMDx Wins Made in North East Medical Life Sciences Award 2022

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

Martin Walton appointed as Chief Financial Officer

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

CAPTURE-XT

TB Host Immune Response Assay (TB-HIRA)

Q-POC Platform

Respiratory Solution